Related Experiment Videos
Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study
László Váróczy1, Lajos Gergely, Margit Zeher
1Division of Immuno-Hematology, Third Department of Medicine, Medical and Health Science Centre, P.O. Box 3, University of Debrecen, 4004 Debrecen, Hungary. varoczy@iiibel.dote.hu
Rheumatology International
|November 12, 2002
Summary
Autoimmune diseases are common in lymphoma patients, affecting 7.6% of non-Hodgkin
Area of Science:
- Oncology
- Immunology
- Rheumatology
Background:
- Lymphoproliferative disorders and autoimmune diseases share clinical similarities.
- Understanding the association between lymphoma and autoimmune conditions is crucial for patient management.
Purpose of the Study:
- To determine the prevalence of autoimmune diseases in patients with malignant lymphomas.
- To investigate the temporal relationship between the onset of autoimmune disease and lymphoma diagnosis/treatment.
Main Methods:
- Retrospective review of 940 patient charts with malignant lymphomas.
- Analysis of patient demographics, autoimmune disease diagnoses, and their timing relative to lymphoma.
Main Results:
- Autoimmune diseases were observed in 7.6% of non-Hodgkin's lymphoma (NHL) and 8.6% of Hodgkin's lymphoma patients.
- In NHL, autoimmune conditions (e.g., Sjögren's syndrome) often preceded lymphoma diagnosis (70%).
- In Hodgkin's lymphoma, autoimmune diseases predominantly developed after malignancy treatment.
Conclusions:
- There is a significant prevalence of autoimmune diseases in patients with malignant lymphomas.
- The timing of autoimmune disease onset differs between NHL and Hodgkin's lymphoma.
- Clinicians should consider the possibility of autoimmune disorders in patients with lymphoproliferative diseases.